BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6398549)

  • 1. Application of a new prostaglandin I2 analogue (APS-306) on cardiopulmonary bypass.
    Takahama T; Kanai F; Iizuka I; Hiraishi M; Yamazaki Z; Idezuki Y; Sudo K; Asano K; Morioka M; Kazama M
    Trans Am Soc Artif Intern Organs; 1984; 30():44-8. PubMed ID: 6398549
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodialysis with the stable prostacyclin analogue CG 4203.
    Maurin N
    Prog Clin Biol Res; 1987; 242():479-84. PubMed ID: 3313422
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system.
    Takahama T; Kanai F; Hiraishi M; Onishi K; Yamazaki Z; Furuse A; Asano K; Yoshitake T; Kazama M
    ASAIO Trans; 1986; 32(1):253-7. PubMed ID: 3535842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of prostaglandins in extracorporeal circulation and hemodialysis].
    Zaorska B
    Pol Tyg Lek; 1981 Jun; 36(23):857-60. PubMed ID: 7024949
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of prostaglandin I2 derivative infusion during experimental cardiopulmonary bypass].
    Matsukura H; Takeda H; Uzawa S; Sakai K; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Jun; 31(6):871-5. PubMed ID: 6352833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prospects of antiaggregant therapy in prevention of atherosclerosis].
    Strano A; Novo S
    G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
    Messini M; Messini F
    Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
    Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
    Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocyte function and systemic effect of prostaglandin I2 inhalation].
    Silberbauer K; Sinzinger H; Burghuber O; Elliott M; Leithner C; Schernthaner G
    Acta Med Austriaca Suppl; 1979; 6():401-3. PubMed ID: 400370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostacyclin].
    Gryglewski RJ; Szczeklik A; Kostka-Trabka E
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1639-44. PubMed ID: 6382206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of prostaglandin I2 infusion during experimental cardiopulmonary bypass (author's transl)].
    Matsukura H; Takeda H; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Feb; 30(2):164-71. PubMed ID: 7047654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of vasculitis with prostaglandins].
    Makino S
    Nihon Rinsho; 1985 Oct; 43(10):2200-5. PubMed ID: 3912548
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostacyclin administration during cardiopulmonary bypass in man.
    Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
    Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
    Ojima M; Fujita K
    Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandins in myocardial: with emphasis on myocardial preservation.
    Jugdutt BI
    Prostaglandins Med; 1981 Aug; 7(2):109-23. PubMed ID: 7025070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostacyclin as a protective factor for blood vessels].
    Leithner C; Sinzinger H; Silberbauer K
    Fortschr Med; 1980 Dec; 98(47-48):1845-9. PubMed ID: 7011923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.